当前位置:首页 - 行情中心 - 尚荣医疗(002551) - 财务分析 - 现金流量表

尚荣医疗

(002551)

  

流通市值:18.09亿  总市值:25.03亿
流通股本:6.11亿   总股本:8.45亿

现金流量表

报告期2026-09-302026-06-302026-03-312025-12-31
公司类型通用通用通用通用
一、经营活动产生的现金流量:
  销售商品、提供劳务收到的现金775,266,580.4400,515,591.17250,704,243.131,138,972,719.88
  收到的税费返还36,384,064.1722,433,598.4410,444,483.2146,453,993.82
  收到其他与经营活动有关的现金14,209,084.59,953,723.994,027,656.1444,245,788.25
  经营活动现金流入小计825,859,729.07432,902,913.6265,176,382.481,229,672,501.95
  购买商品、接受劳务支付的现金543,075,603.76253,861,286.7179,973,795.57710,273,159.76
  支付给职工以及为职工支付的现金177,879,917.46121,287,876.4464,168,403.21263,302,857.89
  支付的各项税费31,062,870.1722,805,034.1811,965,756.2450,110,215.93
  支付其他与经营活动有关的现金94,198,346.8550,671,687.6834,960,248.365,718,737.42
  经营活动现金流出小计846,216,738.24448,625,885291,068,203.321,089,404,971
  经营活动产生的现金流量净额-20,357,009.17-15,722,971.4-25,891,820.84140,267,530.95
二、投资活动产生的现金流量:
  收回投资收到的现金878,153,790.63491,153,790.63114,844,245.661,850,176,112.96
  取得投资收益收到的现金4,948,883.973,693,345.4575,053.33-
  处置固定资产、无形资产和其他长期资产收回的现金净额10,282,00010,282,00010,282,00030,685,030.38
  收到的其他与投资活动有关的现金973,050973,050--
  投资活动现金流入小计894,357,724.6506,102,186.03125,701,298.991,880,861,143.34
  购建固定资产、无形资产和其他长期资产支付的现金10,872,083.898,975,878.726,061,293.11125,262,604.74
  投资支付的现金885,500,000505,000,000135,500,0001,772,410,553.26
  投资活动现金流出小计896,372,083.89513,975,878.72141,561,293.111,897,673,158
  投资活动产生的现金流量净额-2,014,359.29-7,873,692.69-15,859,994.12-16,812,014.66
三、筹资活动产生的现金流量:
  吸收投资收到的现金4,400,000400,000--
  取得借款收到的现金41,019,00011,019,00010,300,00020,000,000
  收到其他与筹资活动有关的现金8,000,0008,000,000289,100.1331,150,000
  筹资活动现金流入小计53,419,00019,419,00010,589,100.1351,150,000
  偿还债务支付的现金104,000,00046,000,000-260,568,902.92
  分配股利、利润或偿付利息支付的现金2,537,952.761,543,844.44359,333.3322,362,939.36
  支付其他与筹资活动有关的现金--67,50060,250,000
  筹资活动现金流出小计106,537,952.7647,543,844.44426,833.33343,181,842.28
  筹资活动产生的现金流量净额-53,118,952.76-28,124,844.4410,162,266.8-292,031,842.28
四、汇率变动对现金及现金等价物的影响412,600.05-1,765,282.18-17,430,667.0211,954,306.18
五、现金及现金等价物净增加额-75,077,721.17-53,486,790.71-49,020,215.18-156,622,019.81
  加:期初现金及现金等价物余额297,365,130.41297,365,130.41297,365,130.41453,987,150.22
  期末现金及现金等价物余额222,287,409.24243,878,339.7248,344,915.23297,365,130.41
补充资料:
  净利润--13,303,576.73--146,208,017.02
  资产减值准备--6,128.77-22,038,371.43
  固定资产和投资性房地产折旧-42,976,640.42-86,856,313.98
  其中:固定资产折旧、油气资产折耗、生产性生物资产折旧-42,976,640.42-86,856,313.98
  无形资产摊销-7,156,635.38-13,967,140.73
  长期待摊费用摊销-621,152.41-857,314.69
  处置固定资产、无形资产和其他长期资产的损失----10,104,229.32
  固定资产报废损失-23,058.81-51,404.99
  公允价值变动损失--3,233,020.24--824,808.57
  财务费用--2,979,819.35--7,548,229.02
  投资损失--4,242,792.06--15,284,664.17
  递延所得税-6,924,674.73--12,964,305.67
  其中:递延所得税资产减少-6,739,490.89--12,299,435.1
    递延所得税负债增加-185,183.84--664,870.57
  存货的减少-16,705,765.31-49,485,601.59
  经营性应收项目的减少-32,360,765.81-74,001,877.58
  经营性应付项目的增加--113,144,536.91-1,641,026.95
  现金的期末余额-243,878,339.7-297,365,130.41
  减:现金的期初余额-297,365,130.41-453,987,150.22
  现金及现金等价物的净增加额--53,486,790.71--156,622,019.81
公告日期2026-10-272026-08-252026-04-282026-04-28
审计意见(境内)标准无保留意见
TOP↑